vs

Side-by-side financial comparison of Sight Sciences, Inc. (SGHT) and SmartRent, Inc. (SMRT). Click either name above to swap in a different company.

SmartRent, Inc. is the larger business by last-quarter revenue ($36.5M vs $20.4M, roughly 1.8× Sight Sciences, Inc.). SmartRent, Inc. runs the higher net margin — -8.9% vs -20.4%, a 11.5% gap on every dollar of revenue. On growth, Sight Sciences, Inc. posted the faster year-over-year revenue change (6.9% vs 3.1%). SmartRent, Inc. produced more free cash flow last quarter ($7.7M vs $-2.0M). Over the past eight quarters, Sight Sciences, Inc.'s revenue compounded faster (2.9% CAGR vs -15.0%).

Sight Sciences, Inc. is a commercial-stage medical technology company focused on developing and commercializing innovative products for treating common eye conditions including glaucoma and dry eye disease. It offers minimally invasive surgical devices and non-surgical care solutions, primarily serving ophthalmology clinicians and patients across the United States.

Budget Rent a Car System, Inc. is an American car rental company that was founded in 1958 in Los Angeles, California by Morris Mirkin. Budget is a subsidiary of the Avis Budget Group, with its operations headquartered in Parsippany, New Jersey.

SGHT vs SMRT — Head-to-Head

Bigger by revenue
SMRT
SMRT
1.8× larger
SMRT
$36.5M
$20.4M
SGHT
Growing faster (revenue YoY)
SGHT
SGHT
+3.8% gap
SGHT
6.9%
3.1%
SMRT
Higher net margin
SMRT
SMRT
11.5% more per $
SMRT
-8.9%
-20.4%
SGHT
More free cash flow
SMRT
SMRT
$9.6M more FCF
SMRT
$7.7M
$-2.0M
SGHT
Faster 2-yr revenue CAGR
SGHT
SGHT
Annualised
SGHT
2.9%
-15.0%
SMRT

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
SGHT
SGHT
SMRT
SMRT
Revenue
$20.4M
$36.5M
Net Profit
$-4.2M
$-3.2M
Gross Margin
87.3%
38.6%
Operating Margin
-18.0%
-10.9%
Net Margin
-20.4%
-8.9%
Revenue YoY
6.9%
3.1%
Net Profit YoY
64.9%
71.6%
EPS (diluted)
$-0.07
$-0.02

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
SGHT
SGHT
SMRT
SMRT
Q4 25
$20.4M
$36.5M
Q3 25
$19.9M
$36.2M
Q2 25
$19.6M
$38.3M
Q1 25
$17.5M
$41.3M
Q4 24
$19.1M
$35.4M
Q3 24
$20.2M
$40.5M
Q2 24
$21.4M
$48.5M
Q1 24
$19.3M
$50.5M
Net Profit
SGHT
SGHT
SMRT
SMRT
Q4 25
$-4.2M
$-3.2M
Q3 25
$-8.2M
$-6.3M
Q2 25
$-11.9M
$-10.9M
Q1 25
$-14.2M
$-40.2M
Q4 24
$-11.8M
$-11.4M
Q3 24
$-11.1M
$-9.9M
Q2 24
$-12.3M
$-4.6M
Q1 24
$-16.3M
$-7.7M
Gross Margin
SGHT
SGHT
SMRT
SMRT
Q4 25
87.3%
38.6%
Q3 25
86.4%
26.4%
Q2 25
84.8%
33.1%
Q1 25
86.2%
32.8%
Q4 24
86.8%
28.7%
Q3 24
83.9%
33.2%
Q2 24
85.8%
35.7%
Q1 24
85.5%
38.5%
Operating Margin
SGHT
SGHT
SMRT
SMRT
Q4 25
-18.0%
-10.9%
Q3 25
-39.7%
-19.4%
Q2 25
-59.6%
-30.5%
Q1 25
-79.2%
-99.9%
Q4 24
-62.5%
-36.6%
Q3 24
-55.7%
-29.0%
Q2 24
-59.2%
-14.3%
Q1 24
-76.4%
-20.1%
Net Margin
SGHT
SGHT
SMRT
SMRT
Q4 25
-20.4%
-8.9%
Q3 25
-41.0%
-17.3%
Q2 25
-61.0%
-28.3%
Q1 25
-80.8%
-97.2%
Q4 24
-62.1%
-32.3%
Q3 24
-54.9%
-24.5%
Q2 24
-57.7%
-9.5%
Q1 24
-84.4%
-15.2%
EPS (diluted)
SGHT
SGHT
SMRT
SMRT
Q4 25
$-0.07
$-0.02
Q3 25
$-0.16
$-0.03
Q2 25
$-0.23
$-0.06
Q1 25
$-0.28
$-0.21
Q4 24
$-0.23
$-0.06
Q3 24
$-0.22
$-0.05
Q2 24
$-0.25
$-0.02
Q1 24
$-0.33
$-0.04

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
SGHT
SGHT
SMRT
SMRT
Cash + ST InvestmentsLiquidity on hand
$92.0M
$104.5M
Total DebtLower is stronger
$42.4M
Stockholders' EquityBook value
$63.9M
$232.1M
Total Assets
$115.3M
$320.9M
Debt / EquityLower = less leverage
0.66×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
SGHT
SGHT
SMRT
SMRT
Q4 25
$92.0M
$104.5M
Q3 25
$92.4M
$100.0M
Q2 25
$101.5M
$105.0M
Q1 25
$108.8M
$125.6M
Q4 24
$120.4M
$142.5M
Q3 24
$118.6M
$163.4M
Q2 24
$118.2M
$187.4M
Q1 24
$127.3M
$204.7M
Total Debt
SGHT
SGHT
SMRT
SMRT
Q4 25
$42.4M
Q3 25
$42.4M
Q2 25
$42.4M
Q1 25
$42.4M
Q4 24
$40.0M
Q3 24
$37.1M
Q2 24
$35.0M
Q1 24
$35.0M
Stockholders' Equity
SGHT
SGHT
SMRT
SMRT
Q4 25
$63.9M
$232.1M
Q3 25
$64.3M
$234.4M
Q2 25
$70.0M
$238.8M
Q1 25
$77.6M
$250.7M
Q4 24
$87.5M
$289.4M
Q3 24
$95.0M
$305.1M
Q2 24
$101.6M
$329.4M
Q1 24
$109.2M
$333.1M
Total Assets
SGHT
SGHT
SMRT
SMRT
Q4 25
$115.3M
$320.9M
Q3 25
$116.3M
$335.8M
Q2 25
$122.0M
$354.0M
Q1 25
$129.7M
$366.1M
Q4 24
$142.8M
$420.2M
Q3 24
$143.6M
$448.6M
Q2 24
$149.7M
$475.3M
Q1 24
$155.6M
$485.5M
Debt / Equity
SGHT
SGHT
SMRT
SMRT
Q4 25
0.66×
Q3 25
0.66×
Q2 25
0.61×
Q1 25
0.55×
Q4 24
0.46×
Q3 24
0.39×
Q2 24
0.34×
Q1 24
0.32×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
SGHT
SGHT
SMRT
SMRT
Operating Cash FlowLast quarter
$-1.8M
$7.7M
Free Cash FlowOCF − Capex
$-2.0M
$7.7M
FCF MarginFCF / Revenue
-9.7%
21.0%
Capex IntensityCapex / Revenue
0.8%
0.0%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-25.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
SGHT
SGHT
SMRT
SMRT
Q4 25
$-1.8M
$7.7M
Q3 25
$-8.7M
$-2.1M
Q2 25
$-7.5M
$-14.9M
Q1 25
$-11.6M
$-12.2M
Q4 24
$-3.5M
$-12.0M
Q3 24
$362.0K
$-3.7M
Q2 24
$-9.5M
$-13.9M
Q1 24
$-9.8M
$-3.3M
Free Cash Flow
SGHT
SGHT
SMRT
SMRT
Q4 25
$-2.0M
$7.7M
Q3 25
$-8.9M
$-2.2M
Q2 25
$-7.8M
$-16.2M
Q1 25
$-14.3M
Q4 24
$-3.6M
$-13.3M
Q3 24
$311.0K
$-3.9M
Q2 24
$-9.5M
$-14.1M
Q1 24
$-9.9M
$-3.4M
FCF Margin
SGHT
SGHT
SMRT
SMRT
Q4 25
-9.7%
21.0%
Q3 25
-44.7%
-6.1%
Q2 25
-39.6%
-42.3%
Q1 25
-34.7%
Q4 24
-18.9%
-37.5%
Q3 24
1.5%
-9.7%
Q2 24
-44.7%
-29.1%
Q1 24
-51.4%
-6.7%
Capex Intensity
SGHT
SGHT
SMRT
SMRT
Q4 25
0.8%
0.0%
Q3 25
0.9%
0.2%
Q2 25
1.1%
3.3%
Q1 25
0.0%
5.3%
Q4 24
0.7%
3.5%
Q3 24
0.3%
0.6%
Q2 24
0.4%
0.5%
Q1 24
0.6%
0.1%

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

SGHT
SGHT

Surgical Glaucoma$19.7M96%
Other$724.0K4%

SMRT
SMRT

Hosted Services$18.1M50%
Hardware Service$12.5M34%
Smart Operations Solutions$2.6M7%
Access Control$2.0M5%
Other Smart Communities Solutions$1.3M3%

Related Comparisons